Androgenic alopecia. Androgenic alopecia, unspecified
Conditions
Interventions
Intervention 1: Intervention group: Patients in the first intervention group consume 1.5 cc of minoxidil solution, each solution equivalent to 20 drops twice a day for 6 months. Intervention 2: Interv
Sponsors
Esfahan University of Medical Sciences
Eligibility
Sex/Gender
Male
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: Satisfaction of the patient and his family to participate in the study Confirmation of androgenetic alopecia by two experienced dermatologists based on Hamilton diagnostic criteria Age 18 to 45 years 2 to 5 hair loss severity according to Hamilton criteria The duration of hair loss is less than 10 years
Exclusion criteria
Exclusion criteria: History or observation of allergies to any of the drugs Minoxidil and Latanoprost, history of heart disease and use of antihypertensive drugs Receiving systemic treatment for androgenic alopecia during the 6 months before the study of other types of alopecia such as alopecia areata, telogen effluvium, anagen effluvium scarring alopecia, any systemic skin disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity of hair loss. Timepoint: Before and after the intervention. Method of measurement: By a skilled physician based on Hamilton-Norwood for male pattern hair loss. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactNazila poostiyan
Esfahan University of Medical Sciences
Outcome results
None listed